SLC47A2 and type 2 diabetes mellitus: The results of this study showed that SLC47A2 rs12943590 predicted insulin resistance improvement in patients with type 2 diabetes mellitus treated with metformin, which may be helpful to guide the clinical use of metformin in the treatment of type 2 diabetes mellitus to some extent.